Literature DB >> 11406154

High-throughput generation and engineering of recombinant human antibodies.

B Krebs1, R Rauchenberger, S Reiffert, C Rothe, M Tesar, E Thomassen, M Cao, T Dreier, D Fischer, A Höss, L Inge, A Knappik, M Marget, P Pack, X Q Meng, R Schier, P Söhlemann, J Winter, J Wölle, T Kretzschmar.   

Abstract

The first version of the Human Combinatorial Antibody Library (HuCAL) is a single-chain Fv-based phage display library (HuCAL-scFv) with 2x10(9) members optimised for high-throughput generation and targeted engineering of human antibodies. 61% of the library genes code for functional scFv as judged by sequencing. We show here that since HuCAL-scFv antibodies are expressed in high levels in Escherichia coli, automated panning and screening in miniaturised settings (96- and 384-well format) have now become feasible. Additionally, the unique modular design of HuCAL-genes and -vectors allows the distinctly facilitated conversion of scFv into Fab, miniantibody and immunoglobulin formats, and the fusion with a variety of effector functions and tags not only convenient for therapeutic applications but also for high-throughput purification and detection. Thus, the HuCAL principle enables the rapid and high-throughput development of human antibodies by optimisation strategies proven useful in classical low molecular weight drug development. We demonstrate in this report that HuCAL is a very convenient source of human antibodies for various applications.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11406154     DOI: 10.1016/s0022-1759(01)00398-2

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  27 in total

1.  Microscale screening of antibody libraries as maytansinoid antibody-drug conjugates.

Authors:  Kalli C Catcott; Molly A McShea; Carl Uli Bialucha; Kathy L Miller; Stuart W Hicks; Parmita Saxena; Thomas G Gesner; Mikias Woldegiorgis; Megan E Lewis; Chen Bai; Michael S Fleming; Seth A Ettenberg; Hans K Erickson; Nicholas C Yoder
Journal:  MAbs       Date:  2016-01-11       Impact factor: 5.857

Review 2.  Current and developing technologies for monitoring agents of bioterrorism and biowarfare.

Authors:  Daniel V Lim; Joyce M Simpson; Elizabeth A Kearns; Marianne F Kramer
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

3.  Basonuclins 1 and 2, whose genes share a common origin, are proteins with widely different properties and functions.

Authors:  Amandine Vanhoutteghem; Philippe Djian
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-04       Impact factor: 11.205

4.  The isolation of novel phage display-derived human recombinant antibodies against CCR5, the major co-receptor of HIV.

Authors:  Moria Shimoni; Alon Herschhorn; Yelena Britan-Rosich; Moshe Kotler; Itai Benhar; Amnon Hizi
Journal:  Viral Immunol       Date:  2013-08       Impact factor: 2.257

5.  Large scale production of phage antibody libraries using a bioreactor.

Authors:  Fortunato Ferrara; Chang-Yub Kim; Leslie A Naranjo; Andrew R M Bradbury
Journal:  MAbs       Date:  2015       Impact factor: 5.857

6.  Structural and biophysical characterization of an epitope-specific engineered Fab fragment and complexation with membrane proteins: implications for co-crystallization.

Authors:  Jennifer L Johnson; Kevin C Entzminger; Jeongmin Hyun; Sibel Kalyoncu; David P Heaner; Ivan A Morales; Aly Sheppard; James C Gumbart; Jennifer A Maynard; Raquel L Lieberman
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2015-03-27

7.  Isolation of human monoclonal antibodies by mammalian cell display.

Authors:  Roger R Beerli; Monika Bauer; Regula B Buser; Myriam Gwerder; Simone Muntwiler; Patrik Maurer; Philippe Saudan; Martin F Bachmann
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

8.  Direct kinetic fingerprinting and digital counting of single protein molecules.

Authors:  Tanmay Chatterjee; Achim Knappik; Erin Sandford; Muneesh Tewari; Sung Won Choi; William B Strong; Evan P Thrush; Kenneth J Oh; Ning Liu; Nils G Walter; Alexander Johnson-Buck
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-31       Impact factor: 11.205

9.  Synthetic antibody libraries focused towards peptide ligands.

Authors:  Christian W Cobaugh; Juan C Almagro; Mark Pogson; Brent Iverson; George Georgiou
Journal:  J Mol Biol       Date:  2008-03-04       Impact factor: 5.469

10.  Anti-EphA2 antibodies decrease EphA2 protein levels in murine CT26 colorectal and human MDA-231 breast tumors but do not inhibit tumor growth.

Authors:  David Kiewlich; Jianhuan Zhang; Cynthia Gross; Wei Xia; Brent Larsen; Ronald R Cobb; Sandra Biroc; Jian-Ming Gu; Takashi Sato; David R Light; Tara Heitner; Joerg Willuda; David Vogel; Felipe Monteclaro; Andrzej Citkowicz; Steve R Roffler; Deborah A Zajchowski
Journal:  Neoplasia       Date:  2006-01       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.